Xiamen Amoytop Biotech
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (25)
The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
Started: 4/28/2025
The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age
Started: 1/20/2026
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Started: 12/4/2019
Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy
Started: 10/16/2020
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Started: 3/1/2013
Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients
Started: 4/1/2012
Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET
Started: 8/29/2024
A Trial of YPEG-rhGH in Children With Short Stature
Started: 2/15/2022
Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children
Started: 12/26/2018
A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease
Started: 3/12/2021
Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Started: 12/1/2013
A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B
Started: 6/1/2014
Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
Started: 7/1/2010
Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Started: 7/1/2010
Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency
Started: 5/31/2026
Safety, Tolerability, and PK/PD of Telpegfilgrastim Injection in Non-pregnant Females of Childbearing
Started: 4/6/2025
Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)
Started: 3/31/2026
Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants
Started: 3/6/2025
Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..
Started: 3/6/2026
Safety, Tolerability, and PK/PD of Telpegfilgrastim in Premenopausal Non-pregnant Females
Started: 3/26/2025
PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual
Started: 9/1/2012
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients
Started: 4/1/2010
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Pegylated-Somatropin in Healthy Volunteers
Started: 1/1/2011
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Assessment of Ypeginterferon Alfa-2a in Healthy Subjects
Started: 1/1/2011
Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT
Started: 9/1/2009